2 Commodity Stocks to Short

An antitrust probe into Google weighed on the tech sector

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MARKET RECAP     9/09/2019
Our #1 Micro-Cap Stock to Own Today On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. That's why we believe anyone who gets in today could turn every $1,000 into $1.54 million (or more)!
Dow Hangs On for Fourth Straight Win By Patrick Martin Share On The Dow snagged its fourth straight win today, good for its longest winning streak since July 15. Trade tailwinds had the Dow up almost 100 points at its session highs to tap the 26,900 level, and despite paring most of those gains, the blue-chip index ultimately finished in the black. However, the S&P 500 and Nasdaq finished mixed, with tech stocks causing a drag. More specifically, the latest antitrust probe from 50 attorneys general has put big-name tech stock Alphabet (GOOGL) in the cross-hairs.  Continue reading for more on today's market, including: Time to short these 2 commodity stocks. Puts on this retail stock could double, signal says.  Microsoft call options are in high demand.  Plus, 2 struggling pharma stocks; a bull note for Energizer; and Anaplan stock approaches oversold status. >> Continue reading...
LATEST HEADLINES
>> Options Traders Take Aim at Altria Amid Juul Drama The FDA is coming down on Juul's marketing practices >> Analyst Note Puts Pressure on Energizer Shorts ENR is looking to test its 200-day moving average >> Bullish Betting Ramps Up as Microsoft Holds Near Highs The weekly 9/13 140-strike call is popular today >> 2 Stocks Stumbling After Drug Data Updates Both names reported poorly received treatment updates today >> Anaplan Stock Now Verges on Oversold Anaplan stock is on pace to close below previously reliable trendline support Sponsored Our #1 Micro-Cap Stock to Own Today On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. That's why we believe anyone who gets in today could turn every $1,000 into $1.54 million (or more)!
To ensure delivery of Schaeffer's Market Recap, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Market Recap or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Market Recap? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MARKET RECAP enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com